Alterations in glucagon secretion in obese rats with hypothalamic lesions. 1980

K Chikamori, and N Nishimura, and F Suehiro, and K Sato, and H Mori, and S Saito

UI MeSH Term Description Entries
D007031 Hypothalamus Ventral part of the DIENCEPHALON extending from the region of the OPTIC CHIASM to the caudal border of the MAMMILLARY BODIES and forming the inferior and lateral walls of the THIRD VENTRICLE. Lamina Terminalis,Preoptico-Hypothalamic Area,Area, Preoptico-Hypothalamic,Areas, Preoptico-Hypothalamic,Preoptico Hypothalamic Area,Preoptico-Hypothalamic Areas
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001120 Arginine An essential amino acid that is physiologically active in the L-form. Arginine Hydrochloride,Arginine, L-Isomer,DL-Arginine Acetate, Monohydrate,L-Arginine,Arginine, L Isomer,DL Arginine Acetate, Monohydrate,Hydrochloride, Arginine,L Arginine,L-Isomer Arginine,Monohydrate DL-Arginine Acetate

Related Publications

K Chikamori, and N Nishimura, and F Suehiro, and K Sato, and H Mori, and S Saito
January 1980, Nihon Naibunpi Gakkai zasshi,
K Chikamori, and N Nishimura, and F Suehiro, and K Sato, and H Mori, and S Saito
April 1985, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
K Chikamori, and N Nishimura, and F Suehiro, and K Sato, and H Mori, and S Saito
January 1985, Endocrine research,
K Chikamori, and N Nishimura, and F Suehiro, and K Sato, and H Mori, and S Saito
April 1963, The American journal of physiology,
K Chikamori, and N Nishimura, and F Suehiro, and K Sato, and H Mori, and S Saito
June 1993, Physiology & behavior,
K Chikamori, and N Nishimura, and F Suehiro, and K Sato, and H Mori, and S Saito
January 1964, Endocrinology,
K Chikamori, and N Nishimura, and F Suehiro, and K Sato, and H Mori, and S Saito
January 1957, Acta physiologica et pharmacologica Neerlandica,
K Chikamori, and N Nishimura, and F Suehiro, and K Sato, and H Mori, and S Saito
April 1957, Archives internationales de pharmacodynamie et de therapie,
K Chikamori, and N Nishimura, and F Suehiro, and K Sato, and H Mori, and S Saito
August 1965, The American journal of physiology,
K Chikamori, and N Nishimura, and F Suehiro, and K Sato, and H Mori, and S Saito
November 1970, Endocrinology,
Copied contents to your clipboard!